MiNA
is an England-based biotechnology company that develops and commercializes saRNA therapeutics for the treatment of cancer and genetic diseases... Read moreMiNA
is an England-based biotechnology company that develops and commercializes saRNA therapeutics for the treatment of cancer and genetic diseases... Read more
News
Jun 12, 2025
FinanzNachrichten
MiNA: MiNA Therapeutics Limited: MiNA Therapeutics Presents New Pre-Clinical Data from Sickle Cell Disease Program at the European Hematology Association 2025 Congress
Dec 07, 2024
Business Wire
Press Release: MiNA : MiNA Therapeutics Presents New Pre-Clinical Data from Lead Sickle Cell Disease Program at the American Society of Hematology Annual Meeting
Apr 05, 2024
Marketscreener
MiNA: MiNA Therapeutics Enters Research Collaboration with Nippon Shinyaku to Develop RNAa Therapeutics Targeting Rare Neurodegenerative Diseases
Jan 24, 2024
FinanzNachrichten
MiNA: MiNA Therapeutics Limited: MiNA Therapeutics Presents New Data for its HbF Program at the Keystone Symposia's Delivery of Nucleic Acid Therapeutics Conference
Oct 28, 2023
Pharamceutical Technology
MiNA: MTL-CEBPA by Mina Therapeutics for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ): Likelihood of Approval
Oct 25, 2023
FinanzNachrichten
MiNA: MiNA Therapeutics Limited: MiNA Therapeutics Highlights Preclinical Research on RNA Activation (RNAa) Therapeutics Presented at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
Apr 26, 2023
Pharamceutical Technology
MiNA: MiNA and BioMarin partner to speed development of RNAa therapies
Apr 25, 2023
Yahoo
MiNA: MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases
Apr 14, 2023
Acrofan
MiNA: MiNA Therapeutics Presents Late-Breaking Positive Phase 1b Data for MTL-CEBPA in Combination with an Anti-PD1 Checkpoint Inhibitor at the Annual Ameri
Apr 11, 2022
FirstWord Pharma
MiNA: MiNA Therapeutics Presents Proof of Mechanism Data on MTL-STING as a Novel Cancer Immunotherapy
MiNA Competitors
1
2
3
4
5
6
7
8
9
10